We evaluated the sensitivity and prognostic value of an enzyme-linked immun
osorbent assay (ELISA) for the measurement of antifilaggrin antibodies (AFA
), using filaggrin purified from human skin as an antigen. The AFA test was
applied to a series of 306 patients with various recent-onset inflammatory
joint diseases. The results were compared to those of the conventional imm
unofluorescence tests for antikeratin antibody (AKA) and antiperinuclear fa
ctor (APF) and of the rheumatoid factor (RF) tests from a previous study. T
here was a very good agreement between the results of the tests for APF and
AFA (kappa-value 0.79 in patients with peripheral poly/oligoarthritis). Th
e agreement between the tests for AKA and AFA was significant but less pron
ounced (kappa-value 0.50). The AFA test detected 10/22 of the RF-negative e
rosive cases, particularly those with a large number of erosive joints. Thu
s, the test for AFA supplements RF in the prediction of erosiveness.